Descriptions

The Mst1/2 kinases are cytosolic Ste20-related kinases activated by autophosphorylation. Designated class II GC kinases, Mst1 and Mst2, share 76% sequence identity and contain an N-terminal catalytic domain, followed successively by an autoinhibitory segment and a coiled-coil SARAH domain that mediates hetero- and homo-dimerisation. Mst1 and Mst2 also become activated in cells undergoing apoptosis from a variety of stimuli. The activation mechanism is unclear, however, once activated, both kinases undergo cleavage by caspase3 at sites just carboxy terminal to their catalytic domains. The resultant catalytic polypeptides display an altered substrate specificity and lack their autoinhibitory domain. The caspase-cleaved catalytic fragments are highly and constitutively active with unrestricted nuclear access.

Autoinhibitory domains (AIDs)

Target domain

30-281 (Protein kinase domain)

Relief mechanism

Cleavage

Assay

Accessory elements

166-189 (Activation loop from InterPro)

Target domain

30-281 (Protein kinase domain)

Relief mechanism

Assay

166-189 (Activation loop from InterPro)

Target domain

30-281 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

1 structures for Q5E9L6

Entry ID Method Resolution Chain Position Source
AF-Q5E9L6-F1 Predicted AlphaFoldDB

63 variants for Q5E9L6

Variant ID(s) Position Change Description Diseaes Association Provenance
rs431955238 3 T>K No EVA
rs431955238 3 T>R No EVA
rs133861322 4 V>G No EVA
rs450541808 5 Q>H No EVA
rs468917209 8 N>T No EVA
rs436040807 10 P>S No EVA
rs466355419 19 E>V No EVA
rs133834483 91 S>R No EVA
rs447622900 125 E>Q No EVA
rs465969680 127 A>G No EVA
rs478146966 130 L>* No EVA
rs445307315 130 L>F No EVA
rs464362564 131 Q>E No EVA
rs437798787 134 L>I No EVA
rs468517227 136 G>E No EVA
rs435444499 137 L>P No EVA
rs447883493 144 R>S No EVA
rs453759634 145 K>E No EVA
rs451374456 163 A>E No EVA
rs476266600 165 L>P No EVA
rs443819977 166 A>V No EVA
rs462300831 168 F>L No EVA
rs466039938 208 W>G No EVA
rs436160547 209 S>L No EVA
rs379222609 252 D>E No EVA
rs137574289 271 T>P No EVA
rs1116389505 310 R>W No EVA
rs434185160 311 E>A No EVA
rs466582720 312 V>G No EVA
rs433920040 319 N>K No EVA
rs435317682 322 E>D No EVA
rs453835218 323 D>Y No EVA
rs801366495 380 T>M No EVA
rs464678881 386 E>A No EVA
rs438039405 386 E>D No EVA
rs467398909 441 V>E No EVA
rs467398909 441 V>G No EVA
rs446715373 445 Q>K No EVA
rs431991856 447 R>K No EVA
rs469112178 450 A>P No EVA
rs436075085 450 A>V No EVA
rs473604002 452 D>G No EVA
rs434140290 457 Q>P No EVA
rs110890031 458 E>G No EVA
rs444423625 459 I>S No EVA
rs471282181 459 I>V No EVA
rs474955190 462 I>S No EVA
rs442071751 463 R>G No EVA
rs479672997 465 K>E No EVA
rs446614486 466 Y>H No EVA
rs458817956 467 Q>H No EVA
rs477330955 468 S>* No EVA
rs450448646 471 Q>L No EVA
rs468977125 472 P>R No EVA
rs435936219 475 D>A No EVA
rs448207275 475 D>E No EVA
rs434202160 478 E>* No EVA
rs474817980 483 R>P No EVA
rs456625821 483 R>W No EVA
rs472724739 484 Q>H No EVA
rs460507858 484 Q>K No EVA
rs440235546 487 F>S No EVA
rs458746273 488 F>L No EVA

No associated diseases with Q5E9L6

3 regional properties for Q5E9L6

Type Name Position InterPro Accession
domain Ubiquitin-like domain 20 - 97 IPR000626
domain Rad60/SUMO-like domain 22 - 91 IPR022617
domain Small ubiquitin-related modifier 1, Ubl domain 21 - 96 IPR046332

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • The caspase-cleaved form cycles between nucleus and cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

4 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
metal ion binding Binding to a metal ion.
protein serine kinase activity Catalysis of the reactions
protein serine/threonine kinase activity Catalysis of the reactions

6 GO annotations of biological process

Name Definition
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
hippo signaling The series of molecular signals mediated by the serine/threonine kinase Hippo or one of its orthologs. In Drosophila, Hippo in complex with the scaffold protein Salvador (Sav), phosphorylates and activates Warts (Wts), which in turn phosphorylates and inactivates the Yorkie (Yki) transcriptional activator. The core fly components hippo, sav, wts and mats are conserved in mammals as STK4/3 (MST1/2), SAV1/WW45, LATS1/2 and MOB1.
intracellular signal transduction The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
protein tetramerization The formation of a protein tetramer, a macromolecular structure consisting of four noncovalently associated identical or nonidentical subunits.
regulation of MAPK cascade Any process that modulates the frequency, rate or extent of signal transduction mediated by the MAP kinase (MAPK) cascade.

18 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q08E52 PAK1 Serine/threonine-protein kinase PAK 1 Bos taurus (Bovine) SS
Q3SWY6 STK25 Serine/threonine-protein kinase 25 Bos taurus (Bovine) PR
Q5ZJK4 STK4 Serine/threonine-protein kinase 4 Gallus gallus (Chicken) SS
Q13188 STK3 Serine/threonine-protein kinase 3 Homo sapiens (Human) SS
Q13043 STK4 Serine/threonine-protein kinase 4 Homo sapiens (Human) EV
Q9Y6E0 STK24 Serine/threonine-protein kinase 24 Homo sapiens (Human) PR
O00506 STK25 Serine/threonine-protein kinase 25 Homo sapiens (Human) PR
Q9JI10 Stk3 Serine/threonine-protein kinase 3 Mus musculus (Mouse) SS
Q9JI11 Stk4 Serine/threonine-protein kinase 4 Mus musculus (Mouse) PR
Q9Z2W1 Stk25 Serine/threonine-protein kinase 25 Mus musculus (Mouse) PR
Q99JT2 Stk26 Serine/threonine-protein kinase 26 Mus musculus (Mouse) PR
Q99KH8 Stk24 Serine/threonine-protein kinase 24 Mus musculus (Mouse) PR
O54748 Stk3 Serine/threonine-protein kinase 3 Rattus norvegicus (Rat) SS
A4K2T0 STK4 Serine/threonine-protein kinase 4 Macaca mulatta (Rhesus macaque) PR
H2L099 gck-1 Germinal center kinase 1 Caenorhabditis elegans PR
Q9NB31 cst-1 Serine/threonine-protein kinase cst-1 Caenorhabditis elegans PR
Q6P3Q4 stk4 Serine/threonine-protein kinase 4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) SS
Q7ZUQ3 stk3 Serine/threonine-protein kinase 3 Danio rerio (Zebrafish) (Brachydanio rerio) SS
10 20 30 40 50 60
METVQLRNPP RRQLKKLDED SLTKQPEEVF DVLEKLGEGS YGSVYKAIHK ETGQIVAIKQ
70 80 90 100 110 120
VPVESDLQEI IKEISIMQQC DSPHVVKYYG SYFKNTDLWI VMEYCGAGSV SDIIRLRNKT
130 140 150 160 170 180
LTEDEIATIL QSTLKGLEYL HFMRKIHRDI KAGNILLNTE GHAKLADFGV AGQLTDTMAK
190 200 210 220 230 240
RNTVIGTPFW MAPEVIQEIG YNCVADIWSL GITAIEMAEG KPPYADIHPM RAIFMIPTNP
250 260 270 280 290 300
PPTFRKPELW SDSFMDFVKQ CLVKSPEQRA TATQLLQHPF VKSAKGVSIL RDLINEAMDV
310 320 330 340 350 360
KLKRQEAQQR EVDQEEEENS EEDELDSGTM VRAAGDEMGT VRVASSMSDG ANTMIEHDDT
370 380 390 400 410 420
LPSQLGTMVI NTEDEEEEGT MKRRDETMQP ARPSFLEYFE QKEKENQINS FGKSVPGPLQ
430 440 450 460 470 480
NSSDWKVPQD GDYEFLKSWT VEDLQKRLLA LDPMMEQEIE EIRQKYQSKR QPILDAIEAK
KRRQQNF